[Clinical trial with a nonamphetaminic anoretic].
The anorexigenic activity of a new compound tricyclic in nature and non-related to amphetamine, mazindol, was studied. The experiment was carried out in 20 patients (17 females and 3 males) aged 17-55 years with a minim overweight of 15% above ideal body weight. Simultaseously, another group of 20 patients (16 females and 4 males) aged 16-55 years with a minim overweight of 15% above ideal body weight were given placebo treatment. Both groups received treatment for a period of eight weeks.